The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis

Ronnie van der Holt; Bob Löwenberg; AK Burnett; WU Knauf; J Shepherd; PP Piccaluga; GJ Ossenkoppele; GEG Verhoef; A Ferrant; M Crump; D Selleslag; M Theobald; MF Fey; E Vellenga; M Dugan; Pieter Sonneveld

doi:10.1182/blood-2005-04-1395

The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis

Ronnie van der Holt
, Bob Löwenberg
, AK Burnett
, WU Knauf
, J Shepherd
, PP Piccaluga
, GJ Ossenkoppele
, GEG Verhoef
, A Ferrant
, M Crump
, D Selleslag
, M Theobald
, MF Fey
, E Vellenga
, M Dugan
, Pieter Sonneveld

Hematology

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

149 Citations (Scopus)

153 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	2646-2654
Number of pages	9
Journal	Blood
Volume	106
Issue number	8
DOIs	https://doi.org/10.1182/blood-2005-04-1395
Publication status	Published - 2005

Research programs

EMC MM-02-41-03

Access to Document

10.1182/blood-2005-04-1395

15994288.pdfFinal published version, 186 KB

http://hdl.handle.net/1765/71064

Cite this

van der Holt, R., Löwenberg, B., Burnett, AK., Knauf, WU., Shepherd, J., Piccaluga, PP., Ossenkoppele, GJ., Verhoef, GEG., Ferrant, A., Crump, M., Selleslag, D., Theobald, M., Fey, MF., Vellenga, E., Dugan, M., & Sonneveld, P. (2005). The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis. Blood, 106(8), 2646-2654. https://doi.org/10.1182/blood-2005-04-1395

@article{b9795e48f9fe4303b0af0b6cddd4e543,

title = "The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis",

author = "\{van der Holt\}, Ronnie and Bob L{\"o}wenberg and AK Burnett and WU Knauf and J Shepherd and PP Piccaluga and GJ Ossenkoppele and GEG Verhoef and A Ferrant and M Crump and D Selleslag and M Theobald and MF Fey and E Vellenga and M Dugan and Pieter Sonneveld",

year = "2005",

doi = "10.1182/blood-2005-04-1395",

language = "Undefined/Unknown",

volume = "106",

pages = "2646--2654",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

number = "8",

}

van der Holt, R , Löwenberg, B, Burnett, AK, Knauf, WU, Shepherd, J, Piccaluga, PP, Ossenkoppele, GJ, Verhoef, GEG, Ferrant, A, Crump, M, Selleslag, D, Theobald, M, Fey, MF, Vellenga, E, Dugan, M & Sonneveld, P 2005, 'The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis', Blood, vol. 106, no. 8, pp. 2646-2654. https://doi.org/10.1182/blood-2005-04-1395

The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis. / van der Holt, Ronnie ; Löwenberg, Bob; Burnett, AK et al.
In: Blood, Vol. 106, No. 8, 2005, p. 2646-2654.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis

AU - van der Holt, Ronnie

AU - Löwenberg, Bob

AU - Burnett, AK

AU - Knauf, WU

AU - Shepherd, J

AU - Piccaluga, PP

AU - Ossenkoppele, GJ

AU - Verhoef, GEG

AU - Ferrant, A

AU - Crump, M

AU - Selleslag, D

AU - Theobald, M

AU - Fey, MF

AU - Vellenga, E

AU - Dugan, M

AU - Sonneveld, Pieter

PY - 2005

Y1 - 2005

U2 - 10.1182/blood-2005-04-1395

DO - 10.1182/blood-2005-04-1395

M3 - Article

C2 - 15994288

SN - 0006-4971

VL - 106

SP - 2646

EP - 2654

JO - Blood

JF - Blood

IS - 8

ER -